Cargando…
Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas
Primary cutaneous lymphomas are heterogenous lymphoproliferative disorders. Some patients show rapid progression and the need for treatment of advanced disease is still unmet. The frequency of each subtype of cutaneous lymphoma varies among different ethnic groups, as do the medical systems found in...
Autor principal: | Sugaya, Makoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537763/ https://www.ncbi.nlm.nih.gov/pubmed/34681738 http://dx.doi.org/10.3390/ijms222011079 |
Ejemplares similares
-
Management of cutaneous T cell lymphoma: new and emerging targets and treatment options
por: Li, Janet Y, et al.
Publicado: (2012) -
New Targeted Treatments for Cutaneous T-cell Lymphomas
por: Bagot, Martine
Publicado: (2017) -
The Role of Molecular Pathology in the Diagnosis of Cutaneous Lymphomas
por: Raess, Philipp W., et al.
Publicado: (2012) -
Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma
por: Yumeen, Sara, et al.
Publicado: (2020) -
Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas
por: Sonego, Benedetta, et al.
Publicado: (2023)